- Consumables
- Assay Kits
- Reagents
- Cell growth assay
- Reporter gene assay
- Immortalized cell lines
- Stem cell lines
- Primary cell lines
- Others
Cell-Based Assay Market size was valued at USD 16.1 billion in 2022 and is expected to reach USD 27.8 billion by 2029, at a CAGR of 8.1% from 2023- 2029. Cell-based Assay is the analytical technique to determine the different parameters such as biochemical or cellular functions of a living cell. Cell-based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell-based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in diagnostics and drug discovery. Cell-based Assay is carried in several therapeutic areas such as cancer, stem cells, immunology, and others. from Argos Soditic for developing its product portfolio. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. An increase in the prevalence and incidence of chronic diseases such as cancer, and drug discovery, an increase in government expenditure, and a rise in the adoption of cell-based consumables by various organizations might fuel the cell-based assay market over the forecast period. Moreover, the rise in demand for biological drugs, increase in the preference for toxicity screening in drugs, and reduction of cost associated with drug discovery are expected to boost the market. However, the lack of skilled professionals for conducting the cell-based assays, the high cost of the instruments, and stringent regulatory policies might hinder the growth of the market.
Global Cell Based Assay Market Summary
Study Period
2023-29
Base Year
2022
CAGR
8.1%
Largest Market
North America
Fastest Growing Market
Europe
Cell Based Assay Market Dynamics
The Cell Based Assay market is in developing stage owing to increase in research and development for new drugs. Increase in the prevalence of various cancer diseases and immunological disorders also expected to propel the market growth. Collaborations, acquisitions & merging, and launch of new products are some of the key strategies followed by the players to increase market share. For instance, in November 2016, Axiogenesis collaborated with Metrion Biosciences Ltd to optimise, validate, and commercialize iPSC derived cell-based Assay for the new drug discovery. Investment from various companies for the R&D activities and entry of start-up companies into the market also bolster the market growth.
North America dominates the market
Cell Based Assay Market Regional Analysis
North America expected to hold a major share in cell based assay market owing to increase in the prevalence of chronic diseases such as cancer, a rise in funding for the R&D activities, developed healthcare infrastructure, and innovation of novel drugs might propel the market growth. Europe holds a significant share in cell based assay market attributed to increase in the prevalence of chronic diseases such as cancer and immune disorders, change in lifestyle, increased healthcare expenditure, an increase in the focus of biopharmaceutical companies on the innovation of new products. Asia Pacific region is expected to grow at a significant rate due to increased investment by pharmaceutical companies, a rise in healthcare expenditure, an increase in the development of new drugs might bolster the cell based assay market over the forecast timeframe.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Cell Based Assay Market Segmentation
By Product Type
By Application
- ADME studies
- Basic research
- Predictive toxicology
- Drug discovery
- Other
By End User
- Diagnostic Centres
- Hospitals
- Biopharmaceutical companies
- Contract research organizations
By Geography
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The cell-based assay market size was valued at USD 16.1 billion in 2022
The cell-based assay market key players are: PerkinElmer Inc. (U.S.) GE Healthcare (UK) ProQinase GmbH (Germany) Danaher Corporation (U.S.) Essen BioScience Inc. (U.S.) Lonza Group (U.S.) Thermo Fisher Scientific Inc. (U.S.) Abenex Capital SA (France) Axiogenesis AG (Germany) Metrion Biosciences Ltd. (U.K.)
The cell-based assay market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Cell Based Assay Market Introduction |
| 2.1.Global Cell Based Assay Market - Taxonomy |
| 2.2.Global Cell Based Assay Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3.Global Cell Based Assay Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Cell Based Assay Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Cell Based Assay Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Consumables |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Assay Kits |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Reagents |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Cell growth assay |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Reporter gene assay |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Immortalized cell lines |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Stem cell lines |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Primary cell lines |
| 5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Others |
| 5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 6. Global Cell Based Assay Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. ADME studies |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Basic research |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Predictive toxicology |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Drug discovery |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Other |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Cell Based Assay Market By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Diagnostic Centres |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Biopharmaceutical companies |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Contract research organizations |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Cell Based Assay Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Cell Based Assay Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Consumables |
| 9.1.2.Assay Kits |
| 9.1.3.Reagents |
| 9.1.4.Cell growth assay |
| 9.1.5.Reporter gene assay |
| 9.1.6.Immortalized cell lines |
| 9.1.7.Stem cell lines |
| 9.1.8.Primary cell lines |
| 9.1.9.Others |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.ADME studies |
| 9.2.2.Basic research |
| 9.2.3.Predictive toxicology |
| 9.2.4.Drug discovery |
| 9.2.5.Other |
| 9.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Diagnostic Centres |
| 9.3.2.Hospitals |
| 9.3.3.Biopharmaceutical companies |
| 9.3.4.Contract research organizations |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Cell Based Assay Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Consumables |
| 10.1.2.Assay Kits |
| 10.1.3.Reagents |
| 10.1.4.Cell growth assay |
| 10.1.5.Reporter gene assay |
| 10.1.6.Immortalized cell lines |
| 10.1.7.Stem cell lines |
| 10.1.8.Primary cell lines |
| 10.1.9.Others |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.ADME studies |
| 10.2.2.Basic research |
| 10.2.3.Predictive toxicology |
| 10.2.4.Drug discovery |
| 10.2.5.Other |
| 10.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Diagnostic Centres |
| 10.3.2.Hospitals |
| 10.3.3.Biopharmaceutical companies |
| 10.3.4.Contract research organizations |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Cell Based Assay Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Consumables |
| 11.1.2.Assay Kits |
| 11.1.3.Reagents |
| 11.1.4.Cell growth assay |
| 11.1.5.Reporter gene assay |
| 11.1.6.Immortalized cell lines |
| 11.1.7.Stem cell lines |
| 11.1.8.Primary cell lines |
| 11.1.9.Others |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.ADME studies |
| 11.2.2.Basic research |
| 11.2.3.Predictive toxicology |
| 11.2.4.Drug discovery |
| 11.2.5.Other |
| 11.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Diagnostic Centres |
| 11.3.2.Hospitals |
| 11.3.3.Biopharmaceutical companies |
| 11.3.4.Contract research organizations |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Cell Based Assay Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Consumables |
| 12.1.2.Assay Kits |
| 12.1.3.Reagents |
| 12.1.4.Cell growth assay |
| 12.1.5.Reporter gene assay |
| 12.1.6.Immortalized cell lines |
| 12.1.7.Stem cell lines |
| 12.1.8.Primary cell lines |
| 12.1.9.Others |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.ADME studies |
| 12.2.2.Basic research |
| 12.2.3.Predictive toxicology |
| 12.2.4.Drug discovery |
| 12.2.5.Other |
| 12.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Diagnostic Centres |
| 12.3.2.Hospitals |
| 12.3.3.Biopharmaceutical companies |
| 12.3.4.Contract research organizations |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Cell Based Assay Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Consumables |
| 13.1.2.Assay Kits |
| 13.1.3.Reagents |
| 13.1.4.Cell growth assay |
| 13.1.5.Reporter gene assay |
| 13.1.6.Immortalized cell lines |
| 13.1.7.Stem cell lines |
| 13.1.8.Primary cell lines |
| 13.1.9.Others |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.ADME studies |
| 13.2.2.Basic research |
| 13.2.3.Predictive toxicology |
| 13.2.4.Drug discovery |
| 13.2.5.Other |
| 13.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Diagnostic Centres |
| 13.3.2.Hospitals |
| 13.3.3.Biopharmaceutical companies |
| 13.3.4.Contract research organizations |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.PerkinElmer Inc. (U.S.) |
| 14.2.2.GE Healthcare (U.K) |
| 14.2.3.ProQinase GmbH (Germany) |
| 14.2.4.Danaher Corporation (U.S.) |
| 14.2.5.Essen BioScience Inc. (U.S.) |
| 14.2.6.Lonza Group (U.S.) |
| 14.2.7.Thermo Fisher Scientific Inc. (U.S.) |
| 14.2.8.Abenex Capital SA (France) |
| 14.2.9.Axiogenesis AG (Germany) |
| 14.2.10.Metrion Biosciences Ltd. (U.K.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- PerkinElmer Inc. (U.S.)
- GE Healthcare (U.K)
- ProQinase GmbH (Germany)
- Danaher Corporation (U.S.)
- Essen BioScience Inc. (U.S.)
- Lonza Group (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Abenex Capital SA (France)
- Axiogenesis AG (Germany)
- Metrion Biosciences Ltd. (U.K.)